Wholesale Acquisition Cost Information for Colorado Prescribers VYVGART® (efgartigimod-fcab)

Download as PDF
 

Colorado law requires prescription drug manufacturers to disclose in writing to Colorado prescribers the Wholesale Acquisition Cost (“WAC”) of marketed drugs when engaging in prescription drug marketing. This disclosure provides the WAC price for the product listed below. 

NDC argenx Product Dosage Form Strength Unit Size Price per mg Wholesale Acquisition Cost*
73475-3041-5 VYVGART (efgartigimod alfa-fcab) Solution in Vial Injection 400 mg in 20 mL (20 mg/ml) Single Dose Vial Single Use Vial $15.17/mg $6,190.38 as of March 8, 2024

2 or 3 vials per dose (weight based)

 

The price to acquire the product listed may differ from the WAC price listed. How much a patient will pay will depend on the patient’s insurance coverage. To find out the exact cost of a prescription, patients should contact their health insurance company. 

Colorado law also requires manufacturers to provide the names of generic prescription drugs from the same “therapeutic class” as the marketed products. Colorado defines “therapeutic class” as “a group of similar drugs that have the same or similar mechanisms of action and are used to treat a specific condition.” There are currently no generic prescription drugs in the same “therapeutic class” (based on the definition of “therapeutic class” under Colorado law) as the listed argenx product. 

*Pricing as of February 17, 2023. The pricing information disclosed above represents the WAC price, which represents the manufacturer’s published catalog or list price for a drug product to wholesalers as reported to third-party drug pricing publishers. WAC does not represent actual transaction prices and does not include other discounts, rebates or reductions in price. Pricing information listed does not imply safety or efficacy of the products, and no comparisons should be made.  

VYVGART is a registered trademark of argenx. ©2023 argenx. All rights reserved.

US-EFG-21-00374 v5 06/2023

 


 

Wholesale Acquisition Cost Information for Colorado Prescribers VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc)

Download as PDF
 

Colorado law requires prescription drug manufacturers to disclose in writing to Colorado prescribers the Wholesale Acquisition Cost (“WAC”) of marketed drugs when engaging in prescription drug marketing. This disclosure provides the WAC price for the product listed below.

NDC argenx Product Dosage Form Strength Unit Size Price per mg Wholesale Acquisition Cost*
73475-3102-3 VYVGART Hytrulo (efgartigimod alfa and hyaluronidase -qvfc) Solution in Vial Injection 1,008 mg efgartigimod alfa and 11,200 Units hyaluronidase per 5.6 mL (180 mg/2,000 Units per mL) Single Use Vial $15.65/mg $15,773.00 as of June 20, 2023

1 vial per dose

 

The price to acquire the product listed may differ from the WAC price listed. How much a patient will pay will depend on the patient’s insurance coverage. To find out the exact cost of a prescription, patients should contact their health insurance company.

Colorado law also requires manufacturers to provide the names of generic prescription drugs from the same “therapeutic class” as the marketed products. Colorado defines “therapeutic class” as “a group of similar drugs that have the same or similar mechanisms of action and are used to treat a specific condition.” There are currently no generic prescription drugs in the same “therapeutic class” (based on the definition of “therapeutic class” under Colorado law) as the listed argenx product.

*Pricing as of June 20, 2023. The pricing information disclosed above represents the WAC price, which represents the manufacturer’s published catalog or list price for a drug product to wholesalers as reported to third-party drug pricing publishers. WAC does not represent actual transaction prices and does not include other discounts, rebates or reductions in price. Pricing information listed does not imply safety or efficacy of the products, and no comparisons should be made. 

VYVGART is a registered trademark of argenx. VYVGART Hytrulo is a trademark of argenx. ©2023 argenx. All rights reserved.

US-ESC-23-00218 v1 06/2023